CliffBio
small molecule

NOXAFIL POWDERMIX KIT

POSACONAZOLE

Loss of exclusivityJanuary 2029FDA regulatory exclusivity expiry
CompanyMERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC

Drug detail

Brand nameNOXAFIL POWDERMIX KIT
Active ingredientPOSACONAZOLE
Strength300MG
Dosage formFOR SUSPENSION, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalMay 2021
Marketing statusRX

Regulatory exclusivity

CodeExpires
I-984January 2029

More from MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.

NOXAFIL POWDERMIX KIT patent cliff — loss of exclusivity January 2029 | CliffBio